This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
APTIOM
SUMITOMO PHARMA CANADA, INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APTIOM in Canada?
A shortage of APTIOM 200MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated June 30, 2026), but it has not started yet.
When will APTIOM be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02426862
Strength
200MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ESLICARBAZEPINE ACETATE
Tier
Unrated
Last Updated
2024-05-30
Reason for Shortage
Delay in shipping of the drug.
Past Reports for This Drug
APTIOM has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from SUMITOMO PHARMA CANADA, INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.